These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 20145023)

  • 1. Roll on genetics of PARK and Parkinsonism in the developing world.
    Kalaria RN; Akinyemi R
    J Neurol Neurosurg Psychiatry; 2010 Feb; 81(2):128. PubMed ID: 20145023
    [No Abstract]   [Full Text] [Related]  

  • 2. Genetic screening reveals high frequency of PARK2 mutations and reduced Parkin expression conferring risk for Parkinsonism in North West India.
    Vinish M; Prabhakar S; Khullar M; Verma I; Anand A
    J Neurol Neurosurg Psychiatry; 2010 Feb; 81(2):166-70. PubMed ID: 19734163
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Juvenile parkinsonism.
    Bhidayasiri R; Pulst SM
    Eur J Paediatr Neurol; 2009 May; 13(3):290-2. PubMed ID: 18571951
    [No Abstract]   [Full Text] [Related]  

  • 4. Juvenile parkinsonism: Differential diagnosis, genetics, and treatment.
    Niemann N; Jankovic J
    Parkinsonism Relat Disord; 2019 Oct; 67():74-89. PubMed ID: 31272925
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical genetics of Parkinson's disease and related disorders.
    Wider C; Wszolek ZK
    Parkinsonism Relat Disord; 2007; 13 Suppl 3():S229-32. PubMed ID: 18267241
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical and genetic studies on familial parkinsonism: the first report on a parkin gene mutation in a Taiwanese family.
    Lu CS; Wu JC; Tsai CH; Chen RS; Chou YH; Hattori N; Yoshino H; Mizuno Y
    Mov Disord; 2001 Jan; 16(1):164-6. PubMed ID: 11215581
    [No Abstract]   [Full Text] [Related]  

  • 7. Unaltered alpha-synuclein blood levels in juvenile Parkinsonism with a parkin exon 4 deletion.
    Miller DW; Crawley A; Gwinn-Hardy K; Lopez G; Nussbaum R; Cookson MR; Singleton AB; Hardy J; Dogu O
    Neurosci Lett; 2005 Feb; 374(3):189-91. PubMed ID: 15663960
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Clinical and genetic analysis of juvenile parkinsonism in Russia].
    Zagorovskaia TB; Illarioshkin SN; Slominskiĭ PA; Ivanova-Smolenskaia IA; Markova ED; Limborskaia SA; Levin OS; Miloserdova OV; Proskokova TN; Bagyeva BKh; Brice A
    Zh Nevrol Psikhiatr Im S S Korsakova; 2004; 104(8):66-72. PubMed ID: 15554146
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mutation analyses in amyotrophic lateral sclerosis/parkinsonism-dementia complex of the Kii peninsula, Japan.
    Tomiyama H; Kokubo Y; Sasaki R; Li Y; Imamichi Y; Funayama M; Mizuno Y; Hattori N; Kuzuhara S
    Mov Disord; 2008 Dec; 23(16):2344-8. PubMed ID: 18759352
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Marked diurnal fluctuation and rest benefit in a patient with parkin mutation.
    Chung SJ; Park HK; Ki CS; Kim MJ; Lee MC
    Mov Disord; 2008 Mar; 23(4):624-6. PubMed ID: 18228570
    [No Abstract]   [Full Text] [Related]  

  • 11. How to predict the risk of Parkinson disease in relatives of parkin mutation carriers: a complex puzzle of age, penetrance, and number of mutated alleles.
    Klein C; Ziegler A
    Arch Neurol; 2008 Apr; 65(4):443-4. PubMed ID: 18413465
    [No Abstract]   [Full Text] [Related]  

  • 12. Update on genetics of parkinsonism.
    Fujioka S; Wszolek ZK
    Neurodegener Dis; 2012; 10(1-4):257-60. PubMed ID: 22261420
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Autosomal dominant parkinsonism: its etiologies and differential diagnoses.
    Hattori N
    Parkinsonism Relat Disord; 2012 Jan; 18 Suppl 1():S1-3. PubMed ID: 22166400
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetics of parkinsonism.
    Gwinn-Hardy K
    Mov Disord; 2002 Jul; 17(4):645-56. PubMed ID: 12210852
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysis of alpha-synuclein, parkin, tau, and UCH-L1 in a Japanese family with autosomal dominant parkinsonism.
    Hasegawa K; Funayama M; Matsuura N; Furusawa H; Sakai F; Kowa H; Obata F
    Eur Neurol; 2001; 46(1):20-4. PubMed ID: 11455179
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biallelic Parkin (PARK2) mutations can cause a bvFTD phenotype without clinically relevant parkinsonism.
    Zimmermann M; Wilke C; Schulte C; Hoffmann J; Klopfer J; Reimold M; Brockmann K; Synofzik M
    Parkinsonism Relat Disord; 2018 Oct; 55():145-147. PubMed ID: 29910155
    [No Abstract]   [Full Text] [Related]  

  • 17. [Autosomal recessive juvenile parkinsonism: its pathogenesis is involved in the ubiquitin-proteasome pathway].
    Hattori N; Shimura H; Kubo S; Suzuki T; Tanaka K; Mizuno Y
    Rinsho Shinkeigaku; 2000 Dec; 40(12):1293-6. PubMed ID: 11464483
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Young-onset parkinsonism due to homozygous duplication of α-synuclein in a consanguineous family.
    Kojovic M; Sheerin UM; Rubio-Agusti I; Saha A; Bras J; Gibbons V; Palmer R; Houlden H; Hardy J; Wood NW; Bhatia KP
    Mov Disord; 2012 Dec; 27(14):1827-9. PubMed ID: 23283657
    [No Abstract]   [Full Text] [Related]  

  • 19. Autosomal recessive juvenile parkinsonism Cys212Tyr mutation in parkin renders lymphocytes susceptible to dopamine- and iron-mediated apoptosis.
    Jimenez Del Rio M; Moreno S; Garcia-Ospina G; Buritica O; Uribe CS; Lopera F; Velez-Pardo C
    Mov Disord; 2004 Mar; 19(3):324-30. PubMed ID: 15022188
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Variable phenotypic expression in families with early-onset Parkinsonism due to PRKN mutations.
    Karkheiran S; Krebs CE; Darvish H; Asadian M; Shahidi GA; Paisán-Ruiz C
    J Neurol; 2014 Jun; 261(6):1223-6. PubMed ID: 24781841
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.